Symbol="ZLAB"
AssetType="Common Stock"
Name="Zai Lab Ltd"
Description="Zai Lab Limited, a biopharmaceutical company, discovers, licenses, develops and markets therapies to treat cancer, autoimmune and infectious diseases in China. The company is headquartered in Shanghai, China."
CIK="1704292"
Exchange="NASDAQ"
Currency="USD"
Country="China"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="4560 JINKE ROAD, BLDG. 1, 4F, PUDONG, SHANGHAI, CHINA"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="2620214000"
EBITDA="-385892992"
PERatio="None"
PEGRatio="None"
BookValue="9.63"
DividendPerShare="0"
DividendYield="0"
EPS="-4.06"
RevenuePerShareTTM="2.619"
ProfitMargin="-1.561"
OperatingMarginTTM="-1.568"
ReturnOnAssetsTTM="-0.196"
ReturnOnEquityTTM="-0.366"
RevenueTTM="251801000"
GrossProfitTTM="-145386000"
DilutedEPSTTM="-4.06"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.429"
AnalystTargetPrice="72.3"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="17.13"
PriceToBookRatio="3.106"
EVToRevenue="12.53"
EVToEBITDA="-4.723"
Beta="1.087"
num_52WeekHigh="53.95"
num_52WeekLow="20.98"
num_50DayMovingAverage="26.97"
num_200DayMovingAverage="33.46"
SharesOutstanding="98839000"
DividendDate="None"
ExDividendDate="None"
symbol="ZLAB"
open="24.35"
high="26.82"
low="24.25"
price="26.51"
volume="737804.00"
latest_trading_day="2023-08-30"
previous_close="23.80"
change="2.71"
change_percent="11.3866%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="547897"
Change_recent_avg="-0.17"
Delta_recent_avg="1.52"
Variance_recent_avg="0.76"
Change_ratio_recent_avg="-0.62"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="1161"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0195.jpeg"
image_negative_thumbnail_id_2="106"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0070.jpeg"
image_neutral_thumbnail_id_1="583"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0016.jpeg"
image_neutral_thumbnail_id_2="545"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0054.jpeg"
image_positive_thumbnail_id_1="991"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0153.jpeg"
image_positive_thumbnail_id_2="613"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0095.jpeg"
image_professor_thumbnail_id_1="1185"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
image_professor_thumbnail_id_2="1189"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
